Inventor
OARE DAVID
US14 patents
⚠️ This page may combine multiple inventors who share the name “OARE DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
7 patentsUS5532359AJul 2, 1996
Ras farnesyl transferase inhibitors
GENENTECH INC192 citations97
US5846932ADec 8, 1998
Receptor specific atrial natriuretic peptides
GENENTECH INC79 citations95
US6872735B2Mar 29, 2005
LFA-1 antagonist compounds
GENENTECH INC51 citations94
US6667318B2Dec 23, 2003
LFA-1 antagonist compounds
GENENTECH INC65 citations94
US6525022B1Feb 25, 2003
Receptor specific atrial natriuretic peptides
GENENTECH INC35 citations92
US5665704ASep 9, 1997
Receptor specific atrial natriuretic peptides
GENENTECH INC56 citations92
US5843941ADec 1, 1998
Ras farnesyl transferase inhibitors
GENENTECH INC48 citations91
THERAVANCE INC
6 patentsUS6693202B1Feb 17, 2004
Muscarinic receptor antagonists
THERAVANCE INC253 citations99
US6635764B2Oct 21, 2003
Therapeutic ureas
THERAVANCE INC149 citations98
US7238709B2Jul 3, 2007
Therapeutic carbamates
THERAVANCE INC25 citations92
US7368463B2May 6, 2008
Substituted 4-amino-1-benzylpiperidine compounds
THERAVANCE INC7 citations74
US8030502B2Oct 4, 2011
Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
THERAVANCE INC0 citations52
US7456203B2Nov 25, 2008
Muscarinic receptor antagonists
THERAVANCE INC1 citations52